NDT Advance Access published online on July 17, 2007
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm329
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The UK Vascular Access Survey—Follow-up data and repeat survey (Chapter 5)
1Derby City Hospital, Uttoxeter Rd, Derby and 2UK Renal Registry, Southmead Hospital, Bristol, UK
Correspondence and offprint requests to: Dr Richard Fluck, UK Renal Registry, Southmead Hospital, Southmead Road, Bristol, BS10 5NB. Email: richard.fluck{at}nhs.net
| Abstract |
|---|
In the 2006 Vascular Access Survey, 51% of all patients commenced renal replacement therapy (RRT) using definitive access. Of patients commencing on haemodialysis HD, 37% commenced with definitive access (31% in the 2005 survey).
Of those known to the renal units for a year or more, only half started HD with definitive access. Around 4% of patients currently receiving HD were in-patients. Around 30% of staphylococcal line infections were methicillin resistant Staphylococcus aureus (MRSA), which was similar to the 2005 survey.
At 6 months after starting RRT, 76% of live patients were using definitive access [defined as the use of peritoneal dialysis (PD), transplant, arteriovenous fistula (AVF) or arteriovenous graft (AVG)] and at 12 months it was 80%.
Of the HD patients starting RRT in April 2005, 65% started using venous catheters, at 6 months this had fallen to 35% and at 12 months to 30%. The use of non-tunnelled lines was <1% by 6 months.
The proportion on PD had fallen slightly at 12 months (from 20% to 16%) by which time 11% had received a transplant, 1% had recovered and 18% had died.
Data returns for the 2006 survey were returned from 37/74 renal units compared with returns from 62 units in the 2005 survey.
Keywords: Chronic kidney disease; dialysis; end stage renal disease; epidemiology; incident patients; infection; prevalent patients; vascular access
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. J. Vandecasteele, J. R. Boelaert, and A. S. De Vriese Staphylococcus aureus Infections in Hemodialysis: What a Nephrologist Should Know Clin. J. Am. Soc. Nephrol., August 1, 2009; 4(8): 1388 - 1400. [Abstract] [Full Text] [PDF] |
||||
